eFFECTOR Therapeutics
(NASDAQ:EFTR)
$0.652
At close: Aug 9
$0.66
0.0080[1.23%]
PreMarket: 7:59PM EDT
Day High/Low- - -
52 Week High/Low0.6 - 8.67
Open / Close- / -
Float / Outstanding20.2M / 41.1M
Vol / Avg.- / 989.1K
Mkt Cap26.8M
P/E1.05
50d Avg. Price1.28
Div / Yield-
Payout Ratio-
EPS0.08
Total Float20.2M

eFFECTOR Therapeutics (NASDAQ:EFTR), Quotes and News Summary

eFFECTOR Therapeutics (NASDAQ: EFTR)

Day High/Low- - -
52 Week High/Low0.6 - 8.67
Open / Close- / -
Float / Outstanding20.2M / 41.1M
Vol / Avg.- / 989.1K
Mkt Cap26.8M
P/E1.05
50d Avg. Price1.28
Div / Yield-
Payout Ratio-
EPS0.08
Total Float20.2M
Sector: Health Care.Industry: Biotechnology
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs). Its product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The eIF4F complex is a central node where two of the most frequently mutated signaling pathways in cancer, the PI3K-AKT, and RAS-MEK pathways, converge to activate the translation of select mRNA into proteins that are frequent culprits in key disease-driving processes.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-07
REV
Q2 2022Est.ActualSurprise
EPS-3.830-0.170 3.6600
REV520.000K2.011M1.491M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

eFFECTOR Therapeutics Questions & Answers

Q
How do I buy eFFECTOR Therapeutics (EFTR) stock?
A

You can purchase shares of eFFECTOR Therapeutics (NASDAQ: EFTR) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are eFFECTOR Therapeutics's (EFTR) competitors?
Q
What is the target price for eFFECTOR Therapeutics (EFTR) stock?
A

The latest price target for eFFECTOR Therapeutics (NASDAQ: EFTR) was reported by Credit Suisse on Thursday, March 17, 2022. The analyst firm set a price target for 14.00 expecting EFTR to rise to within 12 months (a possible 2047.24% upside). 10 analyst firms have reported ratings in the last year.

Q
Current Stock Price for eFFECTOR Therapeutics (EFTR)?
A

The stock price for eFFECTOR Therapeutics (NASDAQ: EFTR) is $0.652 last updated August 9, 2022, 8:00 PM UTC.

Q
Does eFFECTOR Therapeutics (EFTR) pay a dividend?
A

There are no upcoming dividends for eFFECTOR Therapeutics.

Q
When is eFFECTOR Therapeutics (NASDAQ:EFTR) reporting earnings?
A

eFFECTOR Therapeutics’s Q3 earnings are confirmed for Monday, November 7, 2022.

Q
Is eFFECTOR Therapeutics (EFTR) going to split?
A

There is no upcoming split for eFFECTOR Therapeutics.

Q
What sector and industry does eFFECTOR Therapeutics (EFTR) operate in?
A

eFFECTOR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.